Home » Lifestyle » Coronavirus drug from Japan to get first US trial in Massachusetts
Coronavirus drug from Japan to get first US trial in Massachusetts
Sanofi CEO: ‘Everybody gets access’ to potential coronavirus treatment if proven effective
Sanofi CEO Paul Hudson discusses the rapid progress being made in developing a coronavirus vaccine and moving the production of essential pharmaceutical supply from China to Europe.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Continue Reading Below
Three major Massachusetts hospitals are testing a Japanese drug that could be used to treat novel coronavirus patients, The Boston Globe reported, citing a doctor involved in the trials.
The Food and Drug Administration approved a small, randomized trial of the antiviral drug called favipiravir at Massachusetts General Hospital and Brigham and Women's Hospital in Boston and UMass Memorial Medical Center in Worcester.
"We have to prioritize, and this absolutely rose to the top," Dr. Keith T. Flaherty, who is leading a team of experts at MGH to review COVID-19 clinical trials, told the Globe.